S.R. Drugs And Intermediates.Ltd. Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.60 Cr
- Company Age 32 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 150.06 Cr
- Satisfied Charges ₹ 1.08 Cr
- Revenue Growth 2.60%
- Profit Growth 53.74%
- Ebitda 46.14%
- Net Worth 19.56%
- Total Assets 12.30%
About S.R. Drugs And Intermediates.Ltd.
S.R. Drugs And Intermediates Pvt.Ltd. (SDAIP) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 October 1992 and has a history of 32 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.60 Cr.
The company currently has active open charges totaling ₹150.06 Cr. The company has closed loans amounting to ₹1.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hemalatha Chinnamail, Sharada Khairatabad, Satyanarayana Khairtabad, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TG1992PTC014907
- Company No.
014907
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does S.R. Drugs And Intermediates Pvt.Ltd. offer?
S.R. Drugs And Intermediates Pvt.Ltd. offers a wide range of products and services, including Organic and Inorganic Solvents, Chlorinated Solvents, Chemical Reagents & Catalysts, Halogenating Agent, Inorganic Salts.
Who are the key members and board of directors at S.R. Drugs And Intermediates.Ltd.?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Chinnamail  | Managing Director | 22-Oct-1992 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemalatha Chinnamail | Whole-Time Director | 24-Dec-2002 | Current |
| Sharada Khairatabad | Whole-Time Director | 24-Dec-2002 | Current |
| Satyanarayana Khairtabad | Whole-Time Director | 12-Nov-1997 | Current |
Financial Performance of S.R. Drugs And Intermediates.Ltd..
S.R. Drugs And Intermediates Pvt.Ltd., for the financial year ended 2023, experienced modest growth in revenue, with a 2.6% increase. The company also saw a substantial improvement in profitability, with a 53.74% increase in profit. The company's net worth Soared by an impressive increase of 19.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S.R. Drugs And Intermediates.Ltd.?
In 2023, S.R. Drugs And Intermediates.Ltd. had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Arene Life Sciences (Unit 3) Private Limited
Satyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
Arene Life Sciences Private LimitedSatyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
- Arene Life Sciences (Unit 4) Private Limited
Satyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
Srduo Infra LlpSatyanarayana Khairtabad and Satyanarayana Chinnamail are mutual person
Charges (Loans)
₹150.06 Cr
₹1.08 Cr
Charges Breakdown by Lending Institutions
- Karnataka Bank Ltd. : 123.99 Cr
- Others : 26.00 Cr
- Andhra Pradesh State Financial Corporation : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2022 | Karnataka Bank Ltd. | ₹2.96 M | Open |
| 11 Jan 2022 | Karnataka Bank Ltd. | ₹1.72 Cr | Open |
| 30 Dec 2021 | Karnataka Bank Ltd. | ₹8.90 Cr | Open |
| 03 Sep 2020 | Karnataka Bank Ltd. | ₹2.72 Cr | Open |
| 20 Jun 2020 | Karnataka Bank Ltd. | ₹1.00 Cr | Open |
How Many Employees Work at S.R. Drugs And Intermediates.Ltd.?
Unlock and access historical data on people associated with S.R. Drugs And Intermediates.Ltd., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S.R. Drugs And Intermediates.Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S.R. Drugs And Intermediates.Ltd.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
